BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31568521)

  • 1. Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy.
    Ballo O; Stratmann J; Serve H; Steffen B; Finkelmeier F; Brandts C
    PLoS One; 2019; 14(9):e0223013. PubMed ID: 31568521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A higher percentage of leukemic blasts with vacuoles predicts unfavorable outcomes in patients with acute myeloid leukemia.
    Song J; Shang B; Pei Y; Shi M; Niu X; Dou L; Drokow EK; Xu F; Bai Y; Sun K
    Leuk Res; 2021 Oct; 109():106638. PubMed ID: 34116372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapy.
    Short NJ; Benton CB; Chen HC; Qiu P; Gu L; Pierce S; Brandt M; Maiti A; Min TL; Naqvi K; Quintas-Cardama A; Konopleva M; Kadia T; Cortes J; Garcia-Manero G; Ravandi F; Jabbour E; Kantarjian H; Andreeff M
    Am J Hematol; 2016 Dec; 91(12):1221-1226. PubMed ID: 27474808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and Therapeutic Value of Day 14 Bone Marrow Aspiration in Adult Acute Myeloid Leukemia Patients.
    El Gammal MM; Owaidat HM; Rashed RA; Fatah RA; Samra MA
    Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e406-e413. PubMed ID: 31031147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Peripheral Blast Clearance and Day 14 Bone Marrow Biopsy in Predicting Remission Status and Survival After 7+3 Induction in Acute Myeloid Leukemia.
    Covut F; Gupta D; Pinto R; Dambrosio N; El Jurdi N; Meyerson H; Ueda M; Kolk M; Creger R; Metheny L; Cooper BW; Caimi PF; Malek E; Otegbeye F; Lazarus HM; De Lima M; Tomlinson BK
    Clin Lymphoma Myeloma Leuk; 2019 Feb; 19(2):73-82. PubMed ID: 30528848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of the peripheral blood cell counts changes during induction chemotherapy in Chinese patients with adult acute myeloid leukemia.
    Huang YM; Wang YN; Zheng Y; Pan LL; Li Y; Li JG; Wang SY
    Medicine (Baltimore); 2021 Feb; 100(8):e24614. PubMed ID: 33663070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia.
    Arellano M; Pakkala S; Langston A; Tighiouart M; Pan L; Chen Z; Heffner LT; Lonial S; Winton E; Khoury HJ
    Cancer; 2012 Nov; 118(21):5278-82. PubMed ID: 22517268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?
    Campuzano-Zuluaga G; Deutsch Y; Salzberg M; Gomez A; Vargas F; Elias R; Kwon D; Goodman M; Ikpatt OF; Chapman JR; Watts J; Vega F; Swords R
    Am J Hematol; 2016 Mar; 91(3):277-82. PubMed ID: 26663264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34 immunohistochemistry in bone marrow biopsies for early response assessment in acute myeloid leukemia.
    Jain S; Mahapatra M; Pati HP
    Int J Lab Hematol; 2015 Dec; 37(6):746-51. PubMed ID: 26248894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemia.
    Chisini M; Stefanizzi C; Ceglie T; Raponi S; Vozella F; Colafigli G; Salaroli A; D'Angiò M; Mancini M; Diverio D; Breccia M; Mancini F; Minotti C; Trisolini S; Capria S; Testi AM; Guarini A; Latagliata R; De Propris MS; Foà R
    Hematol Oncol; 2017 Dec; 35(4):804-809. PubMed ID: 27400753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutation.
    Zhu HH; Liu YR; Jiang H; Lu J; Qin YZ; Jiang Q; Bao L; Ruan GR; Jiang B; Huang X
    Leuk Res; 2013 Jun; 37(6):624-30. PubMed ID: 23473998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual Disease.
    Ollila TA; Olszewski AJ; Butera JN; Quesenberry MI; Quesenberry PJ; Reagan JL
    Clin Lymphoma Myeloma Leuk; 2018 Mar; 18(3):204-209. PubMed ID: 29433979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes.
    Camburn AE; Petrasich M; Ruskova A; Chan G
    Pathology; 2019 Aug; 51(5):502-506. PubMed ID: 31262563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of Ki67-negative blast cell clone in the high risk group of children treated for acute myeloid leukaemia.
    Nowicki M; Ostalska-Nowicka D; Miśkowiak B
    Folia Histochem Cytobiol; 2006; 44(1):49-52. PubMed ID: 16584092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new prognostic stratification for patients with acute myeloid leukemia].
    Jiang B; Mi YC; Lin D; Cai XJ; Fu MW; Li W; Wang Y; Liu XP; Xue YP; Bian SG; Wang JX
    Zhonghua Nei Ke Za Zhi; 2009 Apr; 48(4):316-20. PubMed ID: 19576124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of day 5 peripheral blast clearance rate in the evaluation of early treatment response and prognosis of patients with acute myeloid leukemia.
    Yu C; Kong QL; Zhang YX; Weng XQ; Wu J; Sheng Y; Jiang CL; Zhu YM; Cao Q; Xiong SM; Li JM; Xi XD; Chen SJ; Chen B
    J Hematol Oncol; 2015 May; 8():48. PubMed ID: 25957890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Marrow MicroRNA-335 Level Predicts the Chemotherapy Response and Prognosis of Adult Acute Myeloid Leukemia.
    Yingchun L; Rong Z; Kun Y; Ying Y; Zhuogang L
    Medicine (Baltimore); 2015 Aug; 94(33):e0986. PubMed ID: 26287405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group.
    Kinoshita A; Miyachi H; Matsushita H; Yabe M; Taki T; Watanabe T; Saito AM; Tomizawa D; Taga T; Takahashi H; Matsuo H; Kodama K; Ohki K; Hayashi Y; Tawa A; Horibe K; Adachi S
    Br J Haematol; 2014 Oct; 167(1):80-6. PubMed ID: 25039450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation.
    Rausei-Mills V; Chang KL; Gaal KK; Weiss LM; Huang Q
    Am J Clin Pathol; 2008 Apr; 129(4):624-9. PubMed ID: 18343790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Time to Clearance of Peripheral Blood Blasts Predicts Complete Remission and Survival in Chinese Adults with Acute Myeloid Leukemia.
    Li X; Zhu H; Zhang Y; Zhao W; Mi J; Hu J; Li J
    Acta Haematol; 2016; 135(4):217-23. PubMed ID: 26967450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.